Friday, 17 Jan 2020

You are here

The ACR17 RheumNow Week in Review - 1 December 2017

Dr Jack Cush reviews nighlights and news from the past 2 weeks on RheumNow.com. This week's report includes new drug approvals, disappointing ACR guidelines, Lyme & Zika, infertility, dermatomyositis skin outcomes and myositis-associated cancer testing.

  1. 45% Pharmacists & 35% Nurses say they receive TEXT orders every day (20%) or >1/wk (35%), yet only 12% said texting… https://t.co/rxo1P2A7mP 
  2. Claims data analyses shows infertile men have higher rates of developing rheumatoid arthritis, multiple sclerosis, psoriasis, thyroiditis, and Grave's disease. https://t.co/6vxMMp54IZ
  3. Hippocrates advises that an ice cube on the skin for 2 min substantially reduces the sting (pain) of a subcutaneous… https://t.co/Ik9dpZgAMV
  4. Metanalysis of 4 RCTs involving 287 patients with chronic widespread pain revealed Vitamin D therapy yielded no sigificant change in VAS… https://t.co/pfBhpqmKHx
  5. In Pre-Clinical RA pts, ACPA pos & ACPA neg behave differently. ACPA pos pts had longer duration of sxs initially but shorter time to arthritis (median 6 vs 18 weeks, p=0.015) than ACPA neg people.  ACPA negative had less  lower extremity Sxs (22% vs 50%)  https://t.co/5hPsYm1NPc
  6. FDA approved rheumatology drugs in 2017: Brodalumab (Siliq); oral Methotrexate solution (Xatmep): Abaloparatide (Tymlos); Tocilizumab (Acterma) GCA: Sarilumab (Kevzara); Guselkumab (Tremfya); Sc Belimumab (Benlysta); Lesinurad w/ allopurinol (Duzallo) https://t.co/CWToiMvidA
  7. Gout risk assoc with Soda & high fructose corn syrup. New NHANES study shows 1209 young adults, 20–30 yrs enrolled 2003–2006 who drank >4 sodas/HFCS drinks per week had a significant 3 fold higher rate of ARTHRITIS.  Risk was not assoc. w/ diet sodas https://t.co/Z8qvW3FgAE
  8. Cancer and myositis significantly increased by Autoantibodies to TIF1-(SIR = 17.28), NXP2 (8.14), SAE1 (12.9) & MSA neg pts (3.99); but not assoc. w/ anti-HMGCR, anti-MDA5 or Myositis specific Abs (Jo-1, PL-7, PL-12, Mi-2, SRP, PL-7, anti-E or anti-OJ) https://t.co/ZZwXzgVvFa
  9. Low energy extracorporeal shock wave therapy shown to successfully treats finger ulcers in scleroderma patients… https://t.co/HNnF7yh7IK
  10. FDA issued safety warning & is investigating Limbrel over 194 adverse event reports regarding Limbrel causing life-threatening drug-induced liver injury and hypersensitivity pneumonitis. Limbrel is a flavinoid nutraceutical used for osteoarthritis https://t.co/1ixhfKbBFu
  11. NY Times review shows physicians spend more time on the EMR than time spent with patients (sometimes twice as much!… https://t.co/F02FoqKh3j
  12. New CDC surveillance report shows the top 7 states for Lyme disease in 2015 include 1) Vermont (78.4/100000/yr); 2)… https://t.co/PaQZgDaWAm
  13. Map of Lyme Disease in the USA 2008-2015. Leading the way : VT, ME, PA, RI, CT, NJ, MA. https://t.co/oUeqT6IfKB https://t.co/49OiOIk64X
  14. New data shows chloroquine may be effective in Rx of Zika virus by markedly reducing amount of Zika virus in matern… https://t.co/CyOVYROGG1 
  15. @JAMADerm: Study shows that less than 40% of #dermatomyositis patients achieve skin remission even w aggressive treatment https://t.co/8
  16. Strawberry Gingivitis associated with Granulomatosis with Polyangiitis. 42 yo w/ epistaxis, painful gingival hyperp… https://t.co/QGoEVjBdWB
  17. FDA approves Fasenra (benralizumab) that binds to the IL-5α receptor, and depletes eosinophils rapidly. Indicated… https://t.co/2CD3qhAzvO 
  18. ACR Clinical Guidelines Flawed by Low Evidence 
  19. Prevalence of Arthritis Grossly Underestimated 
  20. RheumNow ACR 2017 Awards   

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

CDC: 15% of US Adults are Physically Inactivie

All states and territories had more than 15% of adults who were physically inactive and this estimate ranged from 17.3 to 47.7%,  according to new state maps of adult physical inactivity prevalence released today by the Centers for Disease Control and Prevention (CDC).

RheumNow Podcast- The Down Side of Steroids (1.17.20)

Dr. Jack Cush reviews the journal reports and news from RheumNow.com. Be sure to register for RheumNow Live 3/13/2020 in Fort Worth Rheumnow.live.

RheumNow Podcast- Knee Pain Knockout (1.10.20)

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. The podcast covers: best therapies for dactylitis and enthesitis; we have a new knockout for knee pain in OA; and are you on the naughty or nice list when it comes to the new ACR-AF guidelines for arthritis? This and more. Tune in.

2019 Rheumatology Year in Review

2019 was a year marked by major advances, hallmark research, and big news items affecting rheumatology.   Herein you will find our top 10 list, formulated by what I think rheumatologists should know and what will likely change their standards and practice in 2020 and beyond. 

RheumNow Podcast - 2019 Rheumatology Year in Review

Dr. Jack Cush reviews highlights from 2019 on RheumNow.com. Topics covered in this annual review include: superheroes lost; venous thromboembolic events and JAKs; free medical tuition; women in rheumatology; 52 new drug approvals in 2019 and 330 drugs with a 2020 price hike; scleroderma disappointments; novel new treatments and newer tests; the boom of Shingrix; RheumNow.Live - and more.